Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nanomedicine.php on line 2
Nanomedicine
LE WE PMID CA
Nanomedicine1907Nanomedizin

Aids

Amyloidosis

Angiogenesis

Aptamer

Asbestos

Atherosclerosis (BASKET)

Biofilm (Microbiology)

Bioinformatics

Biologicals (Pegylation)

Biomaterials

Cadmium

Cell secretion (Intracellular transport)

Cell tracking

Certolizumab pegol ttTNFalpha

Chemosensation

Contrast agents (X ray contrast agents)

Crohn s disease

Diabetes mellitus (t Insulin Pump)

Drug delivery

Electron tomography

Electrophoretic deposition of biomaterials

Electrospinning of polymers

Enzyme structure and chemistry

Eye (Pharmacology)

Gene transfer

Glucose monitor

Graphene

Heart (Atrial fibrillation)

Hybrid materials

Imaging (Molecular)

Infection (Imaging)

Ion channel (BASKET)

Laboratory medicine

Lipoprotein (HDL)

Liquid crystal

Magnet (Laboratory analysis medical application)

MRT (Contrast agents MRT)

MRT (Instrumentation)

Multiphoton nanosurgery

Nanocolonies

Nanomedicine

Optical imaging (Instrumentation)

Optical micromanipulation

Optics and waves

Polymers

Protein (folding)

Quantum dot

Regeneration of tissues and other biologic structures

Research ethics

RNA (MicroRNA)

Sensors recognizing molecules

Sputtering

Structure det. tissue level to single molecule localization

Structure determination at molecular level and finer

Surface plasmon resonance

Thrombosis (BASKET)

Titanium dioxide TiO2

Tooth (Caries)

Tooth (Implantates)

Toxicology (BASKET)

Tpy chemistry

2007  
1
Nanoparticles-a thoracic toxicology perspective.
[17722227] Yonsei Med J 48(4): 561-72 (2007)
2010  
2
Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.
[19756021] J Cereb Blood Flow Metab 30(1): 15-35 (2010)
2007  
3
Nanoparticles: pharmacological and toxicological significance.
[17245366] Br J Pharmacol 150(5): 552-8 (2007)
2001  
4
Long-circulating and target-specific nanoparticles: theory to practice.
[11356986] Pharmacol Rev 53(2): 283-318 (2001)
2000  
5
Nano and microparticles as controlled drug delivery devices.
[10994037] J Pharm Pharm Sci 3(2): 234-58 (2000)
2006  
6
Nanocarriers: promising vehicle for bioactive drugs.
[16946487] Biol Pharm Bull 29(9): 1790-8 (2006)
2008  
7
Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives.
[20046766] Indian J Pharm Sci 70(4): 431-9 (2008)
2008  
8
Factors affecting the clearance and biodistribution of polymeric nanoparticles.
[18672949] Mol Pharm 5(4): 505-15 (2008)
2008  
9
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
[18510338] Mol Pharm 5(4): 487-95 (2008)
2010  
10
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
[20199661] Part Fibre Toxicol 7(-): 3 (2010)
2010  
11
Deposition and biokinetics of inhaled nanoparticles.
[20205860] Part Fibre Toxicol 7(-): 2 (2010)
2007  
12
Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases.
[17537262] Part Fibre Toxicol 4(-): 4 (2007)
2006  
13
The potential risks of nanomaterials: a review carried out for ECETOC.
[16907977] Part Fibre Toxicol 3(-): 11 (2006)
2005  
14
Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure.
[16242040] Part Fibre Toxicol 2(-): 10 (2005)
2009  
15
On the toxicity of therapeutically used nanoparticles: an overview.
[20130771] J Toxicol 2009(-): 754810 (2009)
2010  
16
Biomimetic nanoparticles: preparation, characterization and biomedical applications.
[20463941] Int J Nanomedicine 5(-): 249-59 (2010)
2010  
17
Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.
[20161986] Int J Nanomedicine 5(-): 37-49 (2010)
2009  
18
Nanomedicine in pulmonary delivery.
[20054434] Int J Nanomedicine 4(-): 299-319 (2009)
2009  
19
Biomedical applications of functionalized fullerene-based nanomaterials.
[20011243] Int J Nanomedicine 4(-): 261-75 (2009)
2009  
20
Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.
[19421366] Int J Nanomedicine 4(-): 1-7 (2009)
2008  
21
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
[18990940] Int J Nanomedicine 3(3): 311-21 (2008)
2008  
22
Nanocrystal technology, drug delivery and clinical applications.
[18990939] Int J Nanomedicine 3(3): 295-309 (2008)
2008  
23
Radionuclide carriers for targeting of cancer.
[18686778] Int J Nanomedicine 3(2): 181-99 (2008)
2008  
24
Magnetic nanoparticles for gene and drug delivery.
[18686777] Int J Nanomedicine 3(2): 169-80 (2008)
2008  
25
Drug delivery and nanoparticles:applications and hazards.
[18686775] Int J Nanomedicine 3(2): 133-49 (2008)
2008  
26
NanoTox: hysteria or scientific studies?
[18686774] Int J Nanomedicine 3(2): i-ii (2008)
2008  
27
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.
[18488412] Int J Nanomedicine 3(1): 1-19 (2008)
2008  
28
Novel opportunities and challenges offered by nanobiomaterials in tissue engineering.
[19337410] Int J Nanomedicine 3(4): 415-24 (2008)
2007  
29
Medicinal applications of fullerenes.
[18203430] Int J Nanomedicine 2(4): 639-49 (2007)
2007  
30
Biomimetic and bioactive nanofibrous scaffolds from electrospun composite nanofibers.
[18203429] Int J Nanomedicine 2(4): 623-38 (2007)
2007  
31
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
[18203428] Int J Nanomedicine 2(4): 609-22 (2007)
2007  
32
Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
[18203427] Int J Nanomedicine 2(4): 595-607 (2007)
2007  
33
VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.
[18203424] Int J Nanomedicine 2(4): 561-6 (2007)
2007  
34
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles.
[18203422] Int J Nanomedicine 2(4): 541-50 (2007)
2007  
35
Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
[18203420] Int J Nanomedicine 2(4): 515-26 (2007)
2007  
36
Cellular response to low adhesion nanotopographies.
[18019836] Int J Nanomedicine 2(3): 373-81 (2007)
2007  
37
Biocompatibility and applications of carbon nanotubes in medical nanorobots.
[18019835] Int J Nanomedicine 2(3): 361-72 (2007)
2007  
38
Nanoparticulate systems for polynucleotide delivery.
[18019834] Int J Nanomedicine 2(3): 353-60 (2007)
2007  
39
Imaging and manipulating the structural machinery of living cells on the micro- and nanoscale.
[18019832] Int J Nanomedicine 2(3): 333-44 (2007)
2007  
40
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.
[18019829] Int J Nanomedicine 2(3): 289-300 (2007)
2007  
41
Nanoparticulate carriers for the treatment of coronary restenosis.
[17722543] Int J Nanomedicine 2(2): 143-61 (2007)
2007  
42
Nanoparticles in modern medicine: state of the art and future challenges.
[17722542] Int J Nanomedicine 2(2): 129-41 (2007)
2006  
43
Chitosan nanoparticles for oral drug and gene delivery.
[17722528] Int J Nanomedicine 1(2): 117-28 (2006)
2006  
44
Nanomedicine: what's in a definition?
[17722527] Int J Nanomedicine 1(2): 115-6 (2006)
2006  
45
Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices.
[17722281] Int J Nanomedicine 1(4): 483-95 (2006)
2006  
46
Silicon nanoparticles: applications in cell biology and medicine.
[17722279] Int J Nanomedicine 1(4): 451-72 (2006)
2006  
47
Nanofibers and their applications in tissue engineering.
[17722259] Int J Nanomedicine 1(1): 15-30 (2006)
2006  
48
Micro- and nanotechnology in cell separation.
[17722258] Int J Nanomedicine 1(1): 3-14 (2006)
2006  
49
Gadonanotubes as new high-performance MRI contrast agents.
[17717970] Int J Nanomedicine 1(3): 291-5 (2006)
2010  
50
Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications.
[20820690] Nanoscale 2(9): 1596-610 (2010)
2010  
51
One-dimensional boron nanostructures: Prediction, synthesis, characterizations, and applications.
[20820721] Nanoscale 2(8): 1375-89 (2010)
2010  
52
Properties, synthesis, and growth mechanisms of carbon nanotubes with special focus on thermal chemical vapor deposition.
[20820718] Nanoscale 2(8): 1306-23 (2010)
2010  
53
The geometric structure of single-walled nanotubes.
[20648281] Nanoscale 2(6): 859-72 (2010)
2010  
54
Carbon nanotubes: promising agents against free radicals.
[20644818] Nanoscale 2(3): 373-80 (2010)
2010  
55
Nanoneedle: a multifunctional tool for biological studies in living cells.
[20644817] Nanoscale 2(3): 363-72 (2010)
2010  
56
Quantum sized, thiolate-protected gold nanoclusters.
[20644816] Nanoscale 2(3): 343-62 (2010)
2010  
57
Small organic molecule templating synthesis of organic-inorganic hybrid materials: their nanostructures and properties.
[20644814] Nanoscale 2(3): 323-34 (2010)
2010  
58
DNA-based nanostructures for molecular sensing.
[20644794] Nanoscale 2(2): 188-97 (2010)
2010  
59
One-dimensional CdS nanostructures: synthesis, properties, and applications.
[20644793] Nanoscale 2(2): 168-87 (2010)
2009  
60
Mechanised nanoparticles for drug delivery.
[20644858] Nanoscale 1(1): 16-39 (2009)
2007  
61
Review: nanoparticles in delivery of cardiovascular drugs.
[17604260] Pak J Pharm Sci 20(4): 340-8 (2007)
2007  
62
Fabrication of solid nanoparticles for drug delivery.
[17545113] Pak J Pharm Sci 20(3): 251-9 (2007)
2006  
63
Review: nanoparticles in drug delivery for the treatment of cancer.
[16935836] Pak J Pharm Sci 19(3): 258-68 (2006)
2006  
64
Porous nanoparticles in drug delivery systems.
[16751130] Pak J Pharm Sci 19(2): 158-69 (2006)
2006  
65
Fabrication of nanoparticles within polymeric pores for controlled release of drug.
[16632458] Pak J Pharm Sci 19(1): 73-84 (2006)
2007  
66
2005  
67
Nanotechnology for the biologist.
[15923216] J Leukoc Biol 78(3): 585-94 (2005)
2009  
68
Single walled carbon nanotubes as reporters for the optical detection of glucose.
[20144355] J Diabetes Sci Technol 3(2): 242-52 (2009)
2007  
69
Colloidal lithography and current fabrication techniques producing in-plane nanotopography for biological applications.
[17015295] J R Soc Interface 4(12): 1-17 (2007)
2009  
70
Manipulation of biological samples using micro and nano techniques.
[20023789] Integr Biol (Camb) 1(1): 30-42 (2009)
2009  
71
Microfluidic sample preparation: cell lysis and nucleic acid purification.
[20023774] Integr Biol (Camb) 1(10): 574-86 (2009)
2009  
72
Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.
[20023754] Integr Biol (Camb) 1(7): 446-51 (2009)
2009  
73
Nanovaccines: recent developments in vaccination.
[20093753] J Biosci 34(6): 995-1003 (2009)
2007  
74
Analytical nanobiotechnology for medicine diagnostics.
[17460792] Mol Biosyst 3(5): 336-42 (2007)
2010  
75
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.
[20411320] Angiogenesis 13(2): 189-202 (2010)
2009  
76
Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis.
[19685150] Angiogenesis 12(4): 325-38 (2009)
2008  
77
Toxicogenomics to improve comprehension of the mechanisms underlying responses of in vitro and in vivo systems to nanomaterials: a review.
[19516964] Curr Genomics 9(8): 571-85 (2008)
2006  
78
Nanoparticles and their biological and environmental applications.
[16952829] J Biosci Bioeng 102(1): 1-7 (2006)
2005  
79
Medical application of functionalized magnetic nanoparticles.
[16233845] J Biosci Bioeng 100(1): 1-11 (2005)
2007  
80
Biogenesis of microbial polyhydroxyalkanoate granules: a platform technology for the production of tailor-made bioparticles.
[17263145] Curr Issues Mol Biol 9(1): 41-62 (2007)
2007  
81
Using micro-electro-mechanical systems (MEMS) to develop diagnostic tools.
[18989418] J Vis Exp -(8): 314 (2007)
2007  
82
Nanotechnology-based drug delivery systems.
[18053152] J Occup Med Toxicol 2(-): 16 (2007)
2008  
83
Polymeric micellar delivery systems in oncology.
[18988667] Jpn J Clin Oncol 38(12): 793-802 (2008)
2008  
84
Nanoparticles for imaging and tumor gene delivery.
[18564615] Tumori 94(2): 264-70 (2008)
2008  
85
Delivery of small interfering RNA. A review and an example of application to a junction oncogene.
[18564614] Tumori 94(2): 254-63 (2008)
2008  
86
Towards safe nanoparticle technologies for nucleic acid therapeutics.
[18564612] Tumori 94(2): 234-45 (2008)
2008  
87
MR and iron magnetic nanoparticles. Imaging opportunities in preclinical and translational research.
[18564611] Tumori 94(2): 226-33 (2008)
2008  
88
Nanotechnology applications in medicine.
[18564609] Tumori 94(2): 206-15 (2008)
2009  
89
Imaging applications of nanotechnology in cancer.
[19876702] Target Oncol 4(3): 169-81 (2009)
2006  
90
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery.
[16928810] Mol Cancer Ther 5(8): 1909-17 (2006)
2008  
91
Therapeutic nanoparticles for drug delivery in cancer.
[18316549] Clin Cancer Res 14(5): 1310-6 (2008)
2008  
92
Pulmonary applications and toxicity of engineered nanoparticles.
[18641236] Am J Physiol Lung Cell Mol Physiol 295(3): L400-11 (2008)
2008  
93
Interactions of nanoparticles with pulmonary structures and cellular responses.
[18263666] Am J Physiol Lung Cell Mol Physiol 294(5): L817-29 (2008)
2005  
94
Smaller is not always better: nanotechnology yields nanotoxicology.
[16214820] Am J Physiol Lung Cell Mol Physiol 289(5): L696-7 (2005)
2008  
95
From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery.
[18946050] Arterioscler Thromb Vasc Biol 28(11): 1879-81 (2008)
2009  
96
Application of semiconductor and metal nanostructures in biology and medicine.
[20008256] Hematology Am Soc Hematol Educ Program -(-): 701-7 (2009)
2005  
97
Drug transport to brain with targeted nanoparticles.
[15717062] NeuroRx 2(1): 108-19 (2005)
2007  
98
Probing the interactions of proteins and nanoparticles.
[17284585] Proc Natl Acad Sci U S A 104(7): 2029-30 (2007)
2006  
99
Microscale technologies for tissue engineering and biology.
[16477028] Proc Natl Acad Sci U S A 103(8): 2480-7 (2006)
2008  
100
Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract.
[18642134] Swiss Med Wkly 138(27-28): 387-91 (2008)
2008  
101
Nanotechnology safety concerns revisited.
[17602205] Toxicol Sci 101(1): 4-21 (2008)
2007  
102
Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments.
[17098817] Toxicol Sci 95(2): 300-12 (2007)
2006  
103
Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety.
[16484287] Toxicol Sci 92(1): 5-22 (2006)
2006  
104
Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.
[16476686] Toxicol Sci 91(1): 14-9 (2006)
2006  
105
Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.
[16407094] Toxicol Sci 90(2): 296-303 (2006)
2006  
106
Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
[16396841] Toxicol Sci 90(1): 23-32 (2006)
2006  
107
Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
[16177233] Toxicol Sci 89(1): 42-50 (2006)
2005  
108
Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
[16120754] Toxicol Sci 88(1): 12-7 (2005)
2005  
109
Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
[16049265] Toxicol Sci 87(2): 316-21 (2005)
2004  
110
Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles.
[14756123] Toxicol Sci 77(1): 3-5 (2004)
2008  
111
New opportunities: the use of nanotechnologies to manipulate and track stem cells.
[18682237] Cell Stem Cell 3(2): 136-46 (2008)
2009  
112
State of academic knowledge on toxicity and biological fate of quantum dots.
[19684286] Toxicol Sci 112(2): 276-96 (2009)
2010  
113
Nanotechnology in ophthalmology.
[20871642] Can J Ophthalmol 45(5): 457-76 (2010)
2010  
114
Paramagnetic liposome nanoparticles for cellular and tumour imaging.
[20480040] Int J Mol Sci 11(4): 1759-76 (2010)
2009  
115
The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system.
[19865518] Int J Mol Sci 10(9): 3776-92 (2009)
2009  
116
Novel applications of nanotechnology in medicine.
[20090129] Indian J Med Res 130(6): 689-701 (2009)
2009  
117
Uses of nanoparticles for central nervous system imaging and therapy.
[19617446] AJNR Am J Neuroradiol 30(7): 1293-301 (2009)
2002  
118
The potential value of iron oxide nanoparticles in brain tumor treatment.
[11950633] AJNR Am J Neuroradiol 23(4): 505 (2002)
2010  
119
Wide contact structures for low-noise nanochannel devices based on a carbon nanotube network.
[21050016] ACS Nano 4(12): 7612-8 (2010)
2011  
120
A boost for the emerging field of RNA nanotechnology.
[21604810] ACS Nano 5(5): 3405-18 (2011)
2008  
121
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.
[19206485] ACS Nano 2(5): 889-96 (2008)
2010  
122
AIDS treatment with novel anti-HIV compounds improved by nanotechnology.
[20373061] AAPS J 12(3): 272-8 (2010)
2007  
123
Nanosystems for simultaneous imaging and drug delivery to T cells.
[17614359] AAPS J 9(2): E171-80 (2007)
2011  
124
Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
[21661727] Acc Chem Res 44(10): 842-52 (2011)
2011  
125
Lipoprotein-inspired nanoparticles for cancer theranostics.
[21557543] Acc Chem Res 44(10): 1105-13 (2011)
2007  
126
Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?
[17474708] Acc Chem Res 40(5): 335-42 (2007)
2010  
127
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates.
[20338204] Adv Drug Deliv Rev 62(6): 592-605 (2010)
2007  
128
Biodegradable nanoparticles for cytosolic delivery of therapeutics.
[17683826] Adv Drug Deliv Rev 59(8): 718-28 (2007)
2007  
129
Functional electrospun nanofibrous scaffolds for biomedical applications.
[17884240] Adv Drug Deliv Rev 59(14): 1392-412 (2007)
2009  
130
In vitro assessments of nanomaterial toxicity.
[19383522] Adv Drug Deliv Rev 61(6): 438-56 (2009)
2009  
131
Effects of nanomaterial physicochemical properties on in vivo toxicity.
[19386275] Adv Drug Deliv Rev 61(6): 457-66 (2009)
2009  
132
Magnetic nanoparticles for theragnostics.
[19389434] Adv Drug Deliv Rev 61(6): 467-77 (2009)
2008  
133
Magnetic nanoparticles in MR imaging and drug delivery.
[18558452] Adv Drug Deliv Rev 60(11): 1252-65 (2008)
2008  
134
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
[18508157] Adv Drug Deliv Rev 60(11): 1241-51 (2008)
2010  
135
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.
[19914317] Adv Drug Deliv Rev 62(3): 346-61 (2010)
2010  
136
Nanoparticles for detection and diagnosis.
[19913581] Adv Drug Deliv Rev 62(3): 316-28 (2010)
2010  
137
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.
[19909778] Adv Drug Deliv Rev 62(3): 284-304 (2010)
2010  
138
Targeted hyperthermia using metal nanoparticles.
[19909777] Adv Drug Deliv Rev 62(3): 339-45 (2010)
2010  
139
Modified natural nanoparticles as contrast agents for medical imaging.
[19900496] Adv Drug Deliv Rev 62(3): 329-38 (2010)
2010  
140
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
[19941919] Adv Drug Deliv Rev 62(4-5): 518-31 (2010)
2010  
141
Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.
[19914316] Adv Drug Deliv Rev 62(4-5): 408-23 (2010)
2011  
142
Nanotechnology for energy-based cancer therapies.
[21984969] Am J Cancer Res 1(4): 508-20 (2011)
2010  
143
2009  
144
Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects.
[19161395] Photochem Photobiol 85(1): 21-32 (2009)
2010  
145
Knitting complex weaves with DNA origami.
[20456942] Curr Opin Struct Biol 20(3): 276-82 (2010)
2010  
146
Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials.
[20091874] Biopolymers 94(1): 1-18 (2010)
2010  
147
Emerging synergy between nanotechnology and implantable biosensors: a review.
[20042326] Biosens Bioelectron 25(7): 1553-65 (2010)
2010  
148
DNA-based applications in nanobiotechnology.
[20652049] J Biomed Biotechnol 2010(-): 715295 (2010)
2010  
149
Rationale for a nanomedicine approach to thrombolytic therapy.
[20876503] Stroke 41(10 Suppl): S42-4 (2010)
2010  
150
Towards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging.
[20603377] Philos Transact A Math Phys Eng Sci 368(1924): 3683-712 (2010)
2010  
151
Determining the size-dependent structure of ligand-free gold-cluster ions.
[20156823] Philos Transact A Math Phys Eng Sci 368(1915): 1211-43 (2010)
2010  
152
Syntheses, structures and properties of primarily nanosized homo/heterometallic palladium CO/PR3-ligated clusters.
[20156827] Philos Transact A Math Phys Eng Sci 368(1915): 1301-32 (2010)
2010  
153
Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles.
[20156828] Philos Transact A Math Phys Eng Sci 368(1915): 1333-83 (2010)
2010  
154
On the application potential of gold nanoparticles in nanoelectronics and biomedicine.
[20156830] Philos Transact A Math Phys Eng Sci 368(1915): 1405-53 (2010)
2004  
155
Decoration of surfaces with size-selected clusters and molecular manipulation at room temperature: precision and uncertainty in organizing atoms.
[15306471] Philos Transact A Math Phys Eng Sci 362(1819): 1195-205 (2004)
2004  
156
Atomic-scale STM experiments on semiconductor surfaces: towards molecular nanomachines.
[15306473] Philos Transact A Math Phys Eng Sci 362(1819): 1217-26 (2004)
2004  
157
2004  
158
Sputtering: survey of observations and derived principles.
[15306275] Philos Transact A Math Phys Eng Sci 362(1814): 29-53 (2004)
2004  
159
Raman spectroscopy of fullerenes and fullerene-nanotube composites.
[15482984] Philos Transact A Math Phys Eng Sci 362(1824): 2375-406 (2004)
2004  
160
Raman spectroscopy of amorphous, nanostructured, diamond-like carbon, and nanodiamond.
[15482988] Philos Transact A Math Phys Eng Sci 362(1824): 2477-512 (2004)
2004  
161
Shape and complexity at the atomic scale: the case of layered nanomaterials.
[15370471] Philos Transact A Math Phys Eng Sci 362(1823): 2039-63 (2004)
2004  
162
Electronic, thermal and mechanical properties of carbon nanotubes.
[15370472] Philos Transact A Math Phys Eng Sci 362(1823): 2065-98 (2004)
2004  
163
2004  
164
Novel nanoscale architectures: coated nanotubes and other nanowires.
[15370474] Philos Transact A Math Phys Eng Sci 362(1823): 2127-42 (2004)
2004  
165
2004  
166
Syntheses and properties of B-C-N and BN nanostructures.
[15370476] Philos Transact A Math Phys Eng Sci 362(1823): 2161-86 (2004)
2004  
167
Scanning tunnelling microscopy of carbon nanotubes.
[15370477] Philos Transact A Math Phys Eng Sci 362(1823): 2187-203 (2004)
2004  
168
Formation and transformation of carbon nanoparticles under electron irradiation.
[15370478] Philos Transact A Math Phys Eng Sci 362(1823): 2205-22 (2004)
2004  
169
Applications of carbon nanotubes in the twenty-first century.
[15370479] Philos Transact A Math Phys Eng Sci 362(1823): 2223-38 (2004)
2004  
170
Carbon nanotube electron sources and applications.
[15370480] Philos Transact A Math Phys Eng Sci 362(1823): 2239-66 (2004)
2003  
171
The carbon nanocosmos: novel materials for the twenty-first century.
[14667298] Philos Transact A Math Phys Eng Sci 361(1813): 2789-806 (2003)
2003  
172
2008  
173
Effects of symmetry crossover in quantum transport in graphene and nanotubes.
[18024358] Philos Transact A Math Phys Eng Sci 366(1863): 221-9 (2008)
2008  
174
Principles of atomic friction: from sticking atoms to superlubric sliding.
[18156127] Philos Transact A Math Phys Eng Sci 366(1869): 1383-404 (2008)
2008  
175
Nanotribology and nanomechanics in nano/biotechnology.
[18192166] Philos Transact A Math Phys Eng Sci 366(1870): 1499-537 (2008)
2009  
176
Dendrimer-based nanoparticles for cancer therapy.
[20008257] Hematology Am Soc Hematol Educ Program -(-): 708-19 (2009)
2006  
177
Synthesis, properties and perspectives of hybrid nanocrystal structures.
[17057845] Chem Soc Rev 35(11): 1195-208 (2006)
2006  
178
Synthesis, structure and properties of metal nanoclusters.
[17057844] Chem Soc Rev 35(11): 1162-94 (2006)
2006  
179
Scanning near-field photolithography--surface photochemistry with nanoscale spatial resolution.
[17057843] Chem Soc Rev 35(11): 1150-61 (2006)
2006  
180
Artificial nanomachines based on interlocked molecular species: recent advances.
[17057842] Chem Soc Rev 35(11): 1135-49 (2006)
2006  
181
First blueprint, now bricks: DNA as construction material on the nanoscale.
[17057840] Chem Soc Rev 35(11): 1111-21 (2006)
2006  
182
Molecular printboards: versatile platforms for the creation and positioning of supramolecular assemblies and materials.
[17057841] Chem Soc Rev 35(11): 1122-34 (2006)
2006  
183
Molecular designer self-assembling peptides.
[17057839] Chem Soc Rev 35(11): 1105-10 (2006)
2006  
184
Imparting size, shape, and composition control of materials for nanomedicine.
[17057838] Chem Soc Rev 35(11): 1095-104 (2006)
2006  
185
Gold nanostructures: engineering their plasmonic properties for biomedical applications.
[17057837] Chem Soc Rev 35(11): 1084-94 (2006)
2006  
186
Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.
[17057836] Chem Soc Rev 35(11): 1068-83 (2006)
2006  
187
Recent progress on nanovehicles.
[17057834] Chem Soc Rev 35(11): 1043-55 (2006)
2006  
188
Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology.
[17057833] Chem Soc Rev 35(11): 1028-42 (2006)
2010  
189
Rheological properties of peptide-based hydrogels for biomedical and other applications.
[20422104] Chem Soc Rev 39(9): 3528-40 (2010)
2004  
190
2005  
191
Photoactive metallocyclodextrins: sophisticated supramolecular arrays for the construction of light activated miniature devices.
[15672176] Chem Soc Rev 34(2): 120-32 (2005)
2007  
192
Self-assembled peptide nanostructures: the design of molecular building blocks and their technological utilization.
[17619686] Chem Soc Rev 36(8): 1263-9 (2007)
2007  
193
2007  
194
Biologically active, synthetic ion transporters.
[17264938] Chem Soc Rev 36(2): 378-89 (2007)
2007  
195
Supramolecular [60]fullerene chemistry on surfaces.
[17264939] Chem Soc Rev 36(2): 390-414 (2007)
2007  
196
Photo-driven molecular devices.
[17173147] Chem Soc Rev 36(1): 77-92 (2007)
2007  
197
Polyoxometalate clusters, nanostructures and materials: from self assembly to designer materials and devices.
[17173149] Chem Soc Rev 36(1): 105-21 (2007)
2007  
198
Rotaxanes as ligands: from molecules to materials.
[17264925] Chem Soc Rev 36(2): 226-35 (2007)
2007  
199
2,2':6',2''-terpyridines: from chemical obscurity to common supramolecular motifs.
[17264927] Chem Soc Rev 36(2): 246-53 (2007)
2007  
200
Calixarene-based multivalent ligands.
[17264928] Chem Soc Rev 36(2): 254-66 (2007)
2007  
201
Functionalized cucurbiturils and their applications.
[17264929] Chem Soc Rev 36(2): 267-79 (2007)
2007  
202
Supramolecular DNA recognition.
[17264930] Chem Soc Rev 36(2): 280-95 (2007)
2007  
203
Supramolecular architectures generated by self-assembly of guanosine derivatives.
[17264931] Chem Soc Rev 36(2): 296-313 (2007)
2007  
204
Release mechanisms for polyelectrolyte capsules.
[17387411] Chem Soc Rev 36(4): 636-49 (2007)
2007  
205
Old materials with new tricks: multifunctional open-framework materials.
[17471401] Chem Soc Rev 36(5): 770-818 (2007)
2005  
206
Stimuli responsive polymers for biomedical applications.
[15726163] Chem Soc Rev 34(3): 276-85 (2005)
2009  
207
Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage.
[19690734] Chem Soc Rev 38(9): 2532-42 (2009)
2005  
208
Supramolecular gels: functions and uses.
[16172672] Chem Soc Rev 34(10): 821-36 (2005)
2005  
209
Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors.
[16239997] Chem Soc Rev 34(11): 970-94 (2005)
2008  
210
Assembly of functional molecular nanostructures on surfaces.
[18224259] Chem Soc Rev 37(3): 490-504 (2008)
2006  
211
Noncovalent interactions of molecules with single walled carbon nanotubes.
[16791335] Chem Soc Rev 35(7): 637-59 (2006)
2006  
212
Size matters: why nanomaterials are different.
[16791330] Chem Soc Rev 35(7): 583-92 (2006)
2008  
213
2008  
214
Designing peptide based nanomaterials.
[18362975] Chem Soc Rev 37(4): 664-75 (2008)
2009  
215
Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.
[19366348] Br J Pharmacol 157(2): 179-94 (2009)
2005  
216
Nanomedicine: current status and future prospects.
[15746175] FASEB J 19(3): 311-30 (2005)
2009  
217
Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency.
[20210709] Biochemistry (Mosc) 74(13): 1567-74 (2009)
2008  
218
Nanocolonies: detection, cloning, and analysis of individual molecules.
[19216706] Biochemistry (Mosc) 73(13): 1361-87 (2008)
2010  
219
Metal-organic frameworks as potential drug carriers.
[20071210] Curr Opin Chem Biol 14(2): 262-8 (2010)
2008  
220
Nano-biophotonics: new tools for chemical nano-analytics.
[18786651] Curr Opin Chem Biol 12(5): 497-504 (2008)
2008  
221
Nanowire sensors for multiplexed detection of biomolecules.
[18804551] Curr Opin Chem Biol 12(5): 522-8 (2008)
2010  
222
Self-organization of grafted polyelectrolyte layers via the coupling of chemical equilibrium and physical interactions.
[20203008] Proc Natl Acad Sci U S A 107(12): 5300-5 (2010)
2008  
223
Tumour-targeted nanomedicines: principles and practice.
[18648371] Br J Cancer 99(3): 392-7 (2008)
2007  
224
Exploiting nanotechnology to target cancer.
[17406364] Br J Cancer 96(9): 1315-9 (2007)
2002  
225
Nanotechnology and applications: an all-language literature survey including books and patents.
[11901071] Clin Chem 48(4): 662-5 (2002)
2007  
226
Applications of nanobiotechnology in clinical diagnostics.
[17890442] Clin Chem 53(11): 2002-9 (2007)
2006  
227
Nanodiagnostics: a new frontier for clinical laboratory medicine.
[16709623] Clin Chem 52(7): 1238-46 (2006)
2010  
228
Superparamagnetic nanoparticles - a tool for early diagnostics.
[20853192] Swiss Med Wkly 140(-): w13081 (2010)
2007  
229
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop.
[18007999] Environ Health Perspect 115(11): 1654-9 (2007)
2007  
230
In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticle exposure: particle number, surface area, or what?
[17384763] Environ Health Perspect 115(2): 187-94 (2007)
2010  
231
Nanodermatology: a bright glimpse just beyond the horizon - part I.
[20844848] Skin Therapy Lett 15(8): 1-4 (2010)
2011  
232
Biomimetic nanostructured materials: potential regulators for osteogenesis?
[21678012] Ann Acad Med Singapore 40(5): 213-10 (2011)
2010  
233
Synthesis, characterization, and application of 1-d cerium oxide nanomaterials: a review.
[20957090] Int J Mol Sci 11(9): 3226-51 (2010)
2011  
234
Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.
[21747714] Int J Mol Sci 12(6): 3888-927 (2011)
2011  
235
Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel.
[21845085] Int J Mol Sci 12(7): 4395-413 (2011)
2011  
236
Nanoparticles and neurotoxicity.
[22016657] Int J Mol Sci 12(9): 6267-80 (2011)
2011  
237
Functioning nanomachines seen in real-time in living bacteria using single-molecule and super-resolution fluorescence imaging.
[21731456] Int J Mol Sci 12(4): 2518-42 (2011)
2011  
238
Application of magnetic nanoparticles to gene delivery.
[21747701] Int J Mol Sci 12(6): 3705-22 (2011)
2009  
239
Effect of nanoparticles on protein folding and fibrillogenesis.
[19333426] Int J Mol Sci 10(2): 646-55 (2009)
2010  
240
Silk fibroin-derived nanoparticles for biomedical applications.
[20662650] Nanomedicine (Lond) 5(5): 807-20 (2010)
2010  
241
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.
[20662649] Nanomedicine (Lond) 5(5): 793-806 (2010)
2010  
242
2011  
243
Targeted nanomedicine for detection and treatment of circulating tumor cells.
[21718169] Nanomedicine (Lond) 6(4): 579-81 (2011)
2011  
244
Copolymer technology for advanced nanomedicine.
[21718170] Nanomedicine (Lond) 6(4): 583-7 (2011)
2011  
245
Nanomedicine for oral chemotherapy.
[21542678] Nanomedicine (Lond) 6(3): 407-10 (2011)
2011  
246
Role of nanobiotechnology in the personalized management of glioblastoma multiforme.
[21542679] Nanomedicine (Lond) 6(3): 411-4 (2011)
2011  
247
Nanoparticle preconditioning for enhanced thermal therapies in cancer.
[21542691] Nanomedicine (Lond) 6(3): 545-63 (2011)
2011  
248
Researching and exploiting nanomaterials useful in forensics and diagnostics. Forward.
[21385121] Nanomedicine (Lond) 6(2): 185-6 (2011)
2011  
249
Nanofabrication techniques for controlled drug-release devices.
[21182411] Nanomedicine (Lond) 6(1): 1-6 (2011)
2011  
250
Nanomaterials for regenerative medicine.
[21182426] Nanomedicine (Lond) 6(1): 157-81 (2011)
2011  
251
Interview: Nanomedicine in oncology: miniaturized means to an enormous end.
[22077461] Nanomedicine (Lond) 6(9): 1495-8 (2011)
2011  
252
The role of nanomedicine in the imaging and therapy of thrombosis.
[22026372] Nanomedicine (Lond) 6(8): 1291-3 (2011)
2011  
253
Nanoparticles for rapid detection of microbial threats.
[22026373] Nanomedicine (Lond) 6(8): 1295-6 (2011)
2011  
254
Nanomedicine for diabetes treatment.
[22026374] Nanomedicine (Lond) 6(8): 1297-300 (2011)
2011  
255
Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold?
[21929450] Nanomedicine (Lond) 6(7): 1133-5 (2011)
2011  
256
Therapeutic compliance of nanomedicine in Alzheimer's disease.
[21929451] Nanomedicine (Lond) 6(7): 1137-9 (2011)
2011  
257
Nanotechnology for multimodal imaging.
[21929452] Nanomedicine (Lond) 6(7): 1141-4 (2011)
2010  
258
Antibody engineering promotes nanomedicine for cancer treatment.
[21039191] Nanomedicine (Lond) 5(8): 1141-5 (2010)
2010  
259
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.
[20394539] Nanomedicine (Lond) 5(3): 485-505 (2010)
2009  
260
RNAi nanoparticles in the service of personalized medicine.
[19958219] Nanomedicine (Lond) 4(8): 853-5 (2009)
2010  
261
Microscale oral delivery devices incorporating nanoparticles.
[20148626] Nanomedicine (Lond) 5(2): 161-3 (2010)
2010  
262
Nanogels in the race for drug delivery.
[20148627] Nanomedicine (Lond) 5(2): 165-8 (2010)
2010  
263
Nanomedicine-based cancer targeting: a new weapon in an old war.
[20025458] Nanomedicine (Lond) 5(1): 3-5 (2010)
2007  
264
2007  
265
Nanomedicine: how it could reshape clinical practice.
[17716126] Nanomedicine (Lond) 2(4): 401-5 (2007)
2007  
266
Potential uses of carbon nanotubes in the medical field: how worried should patients be?
[17716127] Nanomedicine (Lond) 2(4): 407-10 (2007)
2007  
267
Focus on nanoparticles for cancer diagnosis and therapeutics.
[17976025] Nanomedicine (Lond) 2(5): 647-8 (2007)
2007  
268
Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat.
[17976026] Nanomedicine (Lond) 2(5): 649-52 (2007)
2007  
269
Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection.
[18095842] Nanomedicine (Lond) 2(6): 753-8 (2007)
2007  
270
Strategies for developing and commercializing nanobio drugs, diagnostics and devices.
[17716115] Nanomedicine (Lond) 2(2): 137-41 (2007)
2007  
271
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
[17716116] Nanomedicine (Lond) 2(2): 143-7 (2007)
2009  
272
Nanostructured surfaces: cell engineering and cell biology.
[19331531] Nanomedicine (Lond) 4(3): 247-8 (2009)
2009  
273
Role of nanobiotechnology in the development of personalized medicine.
[19331532] Nanomedicine (Lond) 4(3): 249-52 (2009)
2009  
274
The photonic nanomedicine revolution: let the human side of nanotechnology emerge.
[19505237] Nanomedicine (Lond) 4(4): 369-71 (2009)
2009  
275
Update on carbon nanotube toxicity.
[19505238] Nanomedicine (Lond) 4(4): 373-5 (2009)
2009  
276
Conference scene - nanotoxicology: health and environmental impacts.
[19505241] Nanomedicine (Lond) 4(4): 385-90 (2009)
2009  
277
Delivering the goods: realizing the clinical potential of RNAi.
[19663585] Nanomedicine (Lond) 4(6): 595-8 (2009)
2009  
278
The promise of nanomedicine for ocular disease.
[19663586] Nanomedicine (Lond) 4(6): 599-604 (2009)
2009  
279
Testing strategies for the safety of nanoparticles used in medical applications.
[19663587] Nanomedicine (Lond) 4(6): 605-7 (2009)
2008  
280
Electron tomography in nanoparticle imaging and analysis.
[18393671] Nanomedicine (Lond) 3(1): 125-31 (2008)
2008  
281
Role of nanomedicines in cell-based therapeutics.
[18393661] Nanomedicine (Lond) 3(1): 5-8 (2008)
2008  
282
From fluorescence nanoscopy to nanoscopic medicine.
[18393640] Nanomedicine (Lond) 3(1): 1-4 (2008)
2008  
283
Implications of recent US Supreme Court IP ruling for nanomedicine patents.
[18373420] Nanomedicine (Lond) 3(2): 141-3 (2008)
2008  
284
Theranostic nanomedicine for cancer.
[18373419] Nanomedicine (Lond) 3(2): 137-40 (2008)
2008  
285
Environmental challenges for nanomedicine.
[18817463] Nanomedicine (Lond) 3(5): 605-8 (2008)
2008  
286
Function follows form: shape complementarity and nanoparticle toxicity.
[18817462] Nanomedicine (Lond) 3(5): 601-3 (2008)
2009  
287
Conference scene: innovative medical devices and nanotechnology: 1-day interactive workshop.
[19839807] Nanomedicine (Lond) 4(7): 709-12 (2009)
2009  
288
Conference scene: 2nd annual European conference for clinical nanomedicine.
[19839806] Nanomedicine (Lond) 4(7): 705-8 (2009)
2009  
289
The future of theranostic nanoagents.
[19839803] Nanomedicine (Lond) 4(7): 693-5 (2009)
2009  
290
Neurodegenerative disorders and nanoformulated drug development.
[19572820] Nanomedicine (Lond) 4(5): 541-55 (2009)
2009  
291
NanoART, neuroAIDS and CNS drug delivery.
[19572821] Nanomedicine (Lond) 4(5): 557-74 (2009)
2009  
292
Regulatory and scientific barriers to the safety evaluation of medical nanotechnologies.
[19572812] Nanomedicine (Lond) 4(5): 495-8 (2009)
2009  
293
Brain targeting PBCA nanoparticles and the blood-brain barrier.
[19572813] Nanomedicine (Lond) 4(5): 499-502 (2009)
2009  
294
Current advances in research and clinical applications of PLGA-based nanotechnology.
[19435455] Expert Rev Mol Diagn 9(4): 325-41 (2009)
2010  
295
A review of nanoparticle functionality and toxicity on the central nervous system.
[20519209] J R Soc Interface 7 Suppl 4(-): S411-22 (2010)
2010  
296
Electrophoretic deposition of biomaterials.
[20504802] J R Soc Interface 7 Suppl 5(-): S581-613 (2010)
2005  
297
Statistical geometry of pores and statistics of porous nanofibrous assemblies.
[16849188] J R Soc Interface 2(4): 309-18 (2005)
2010  
298
Optical imaging-guided cancer therapy with fluorescent nanoparticles.
[19759055] J R Soc Interface 7(42): 3-18 (2010)
2009  
299
Bioinspired interface for nanobiodevices based on phospholipid polymer chemistry.
[19324688] J R Soc Interface 6 Suppl 3(-): S279-91 (2009)
2009  
300
Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.
[19364722] J R Soc Interface 6 Suppl 3(-): S325-39 (2009)
2010  
301
Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.
[19940000] J R Soc Interface 7 Suppl 1(-): S55-66 (2010)
2010  
302
Bioresponsive nanosensors in medical imaging.
[19846442] J R Soc Interface 7 Suppl 1(-): S83-91 (2010)
2008  
303
Polymersomes: a new multi-functional tool for cancer diagnosis and therapy.
[18572025] Methods 46(1): 25-32 (2008)
2011  
304
Is nanomedicine still promising?
[21677362] Oncotarget 2(6): 430-2 (2011)
2008  
305
Assembling materials with DNA as the guide.
[18818351] Science 321(5897): 1795-9 (2008)
2010  
306
Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.
[20067234] Chem Rev 110(5): 2921-59 (2010)
2010  
307
Nanoparticle-induced pulmonary toxicity.
[20719818] Exp Biol Med (Maywood) 235(9): 1025-33 (2010)
2009  
308
Engineering nanomaterial surfaces for biomedical applications.
[19596820] Exp Biol Med (Maywood) 234(10): 1128-39 (2009)
2010  
309
Nanoparticles and the immune system.
[20016026] Endocrinology 151(2): 458-65 (2010)
2010  
310
Nanoparticles for molecular imaging--an overview.
[20016027] Endocrinology 151(2): 474-81 (2010)
2010  
311
A tiny touch: activation of cell signaling pathways with magnetic nanoparticles.
[20016028] Endocrinology 151(2): 451-7 (2010)
2007  
312
Semiconductor and ceramic nanoparticle films deposited by chemical bath deposition.
[17487315] Phys Chem Chem Phys 9(18): 2181-96 (2007)
2007  
313
Layer-by-layer assembly as a versatile bottom-up nanofabrication technique for exploratory research and realistic application.
[17492095] Phys Chem Chem Phys 9(19): 2319-40 (2007)
2008  
314
Physical electrochemistry of nanostructured devices.
[18075682] Phys Chem Chem Phys 10(1): 49-72 (2008)
2008  
315
Single molecule magnets: from thin films to nano-patterns.
[18231680] Phys Chem Chem Phys 10(6): 784-93 (2008)
2005  
316
The scanned nanopipette: a new tool for high resolution bioimaging and controlled deposition of biomolecules.
[16189604] Phys Chem Chem Phys 7(15): 2859-66 (2005)
2006  
317
Absorption and scattering microscopy of single metal nanoparticles.
[16871337] Phys Chem Chem Phys 8(30): 3486-95 (2006)
2010  
318
Polymer-functionalized gold nanoparticles as versatile sensing materials.
[21157089] Anal Sci 26(12): 1219-28 (2010)
2010  
319
Functionalized nanoparticles and nanostructured surfaces for surface-assisted laser desorption/ionization mass spectrometry.
[21157090] Anal Sci 26(12): 1229-40 (2010)
2010  
320
Recent nanoarchitectures in metal nanoparticle-modified electrodes for electroanalysis.
[20065580] Anal Sci 26(1): 1-12 (2010)
2007  
321
Colorimetric biosensors based on DNA-nanoparticle conjugates.
[17213617] Anal Sci 23(1): 17-20 (2007)
2008  
322
Fabrication and analytical applications of hybrid mesoporous membranes.
[18187846] Anal Sci 24(1): 25-30 (2008)
2006  
323
Nanotechnology and nanomedicine: a primer.
[17225846] J Natl Med Assoc 98(12): 1985-8 (2006)
2006  
324
Nanomaterial health effects--part 1: background and current knowledge.
[16628969] WMJ 105(2): 16-20 (2006)
2010  
325
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
[20172613] Trends Pharmacol Sci 31(5): 199-205 (2010)
2008  
326
Sheddable coatings for long-circulating nanoparticles.
[17551809] Pharm Res 25(1): 55-71 (2008)
2011  
327
[Control and analysis for intracellular trafficking of nucleic acids based on quantitative and dynamic imaging].
[22041692] Yakugaku Zasshi 131(11): 1545-56 (2011)
2009  
328
Toxicology of engineered nanomaterials - a review of carcinogenic potential.
[20192569] Asian Pac J Cancer Prev 10(6): 975-80 (2009)
2007  
329
Ethical and scientific issues of nanotechnology in the workplace.
[18813467] Cien Saude Colet 12(5): 1319-32 (2007)
2010  
330
Nanotechnology applications in surgical oncology.
[20059343] Annu Rev Med 61(-): 359-73 (2010)
2010  
331
Strong nanocomposites with Ca, PO(4), and F release for caries inhibition.
[19948941] J Dent Res 89(1): 19-28 (2010)
2011  
332
Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
[21501554] J Pharm Pharm Sci 14(1): 67-77 (2011)
2011  
333
Present status of nanoparticle research for treatment of tuberculosis.
[21501557] J Pharm Pharm Sci 14(1): 100-16 (2011)
2010  
334
Nanoparticle-mediated interleukin-12 cancer gene therapy.
[21092717] J Pharm Pharm Sci 13(3): 472-85 (2010)
2010  
335
Gold nanoparticles: opportunities and challenges in nanomedicine.
[20408736] Expert Opin Drug Deliv 7(6): 753-63 (2010)
2010  
336
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
[20331355] Expert Opin Drug Deliv 7(4): 479-95 (2010)
2007  
337
Aquatic environmental nanoparticles.
[18049768] J Environ Monit 9(12): 1306-16 (2007)
2007  
338
Nanomaterials and the environment: uses, methods and measurement.
[17968441] J Environ Monit 9(11): 1154-61 (2007)
2011  
339
The art of engineering viral nanoparticles.
[21047140] Mol Pharm 8(1): 29-43 (2011)
2008  
340
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
[18547053] Mol Pharm 5(4): 474-86 (2008)
2009  
341
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
[19366234] Mol Pharm 6(4): 1041-51 (2009)
2010  
342
2010  
343
Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine.
[20493220] J Control Release 146(1): 2-5 (2010)
2010  
344
Hard and soft micro- and nanofabrication: An integrated approach to hydrogel-based biosensing and drug delivery.
[20036310] J Control Release 141(3): 303-13 (2010)
2007  
345
Nanotechnology: What it can do for drug delivery.
[17532520] J Control Release 120(1-2): 1-3 (2007)
2004  
346
2010  
347
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.
[21969738] Indian J Pharm Sci 72(6): 675-88 (2010)
2011  
348
Engineered nanomaterials: exposures, hazards, and risk prevention.
[21418643] J Occup Med Toxicol 6(-): 7 (2011)
2010  
349
Multi-photon nanosurgery in live brain.
[20725602] Front Neuroenergetics 2(-): - (2010)
2009  
350
Dendrimers in medical nanotechnology.
[19150767] IEEE Eng Med Biol Mag 28(1): 12-22 (2009)
2010  
351
Contribution of biologically derived nanoparticles to disease.
[19767047] Surgery 147(2): 181-4 (2010)
2009  
352
Nanoparticle PEBBLE sensors in live cells and in vivo.
[20098636] Annu Rev Anal Chem (Palo Alto Calif) 2(-): 57-76 (2009)
2008  
353
Biopharmaceutics and therapeutic potential of engineered nanomaterials.
[18855608] Curr Drug Metab 9(8): 697-709 (2008)
2011  
354
2012  
355
Noble metal nanoparticles applications in cancer.
[22007307] J Drug Deliv 2012(-): 751075 (2012)
2012  
356
Lipoplatin formulation review article.
[21904682] J Drug Deliv 2012(-): 581363 (2012)
2009  
357
Nanotechnology-based electrochemical sensors for biomonitoring chemical exposures.
[19018275] J Expo Sci Environ Epidemiol 19(1): 1-18 (2009)
2005  
358
RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
[16430131] J Nanosci Nanotechnol 5(12): 1964-82 (2005)
2007  
359
Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells.
[17663266] J Nanosci Nanotechnol 7(7): 2466-72 (2007)
2010  
360
Hazard assessments of manufactured nanomaterials.
[20972355] J Occup Health 52(6): 325-34 (2010)
2011  
361
Carbon nanotubes in nanocomposites and hybrids with hydroxyapatite for bone replacements.
[21776341] J Tissue Eng 2011(-): 674287 (2011)
2011  
362
An evaluation of acute toxicity of colloidal silver nanoparticles.
[21712637] J Vet Med Sci 73(11): 1417-23 (2011)
2010  
363
The emerging field of RNA nanotechnology.
[21102465] Nat Nanotechnol 5(12): 833-42 (2010)
2011  
364
Oxidative Stress Induced in Microorganisms by Zero-valent Iron Nanoparticles.
[21791884] Microbes Environ 26(4): 271-81 (2011)
2011  
365
More effective nanomedicines through particle design.
[21695781] Small 7(14): 1919-31 (2011)
2008  
366
2010  
367
Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.
[21611034] Biomed Imaging Interv J 6(2): e12 (2010)
2009  
368
Aptamer-encoded nanopore for ultrasensitive detection of bioterrorist agent ricin at single-molecule resolution.
[19964179] Conf Proc IEEE Eng Med Biol Soc 2009(-): 6699-702 (2009)
2009  
369
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
[20402623] Crit Rev Ther Drug Carrier Syst 26(6): 523-80 (2009)
2011  
370
Toxicity evaluations of various carbon nanomaterials.
[21597228] Dent Mater J 30(3): 245-63 (2011)
2007  
371
Nanomaterial labels in electrochemical immunosensors and immunoassays.
[18371644] Talanta 74(3): 308-17 (2007)
2009  
372
2010  
373
Nanoparticles for retinal gene therapy.
[20452457] Prog Retin Eye Res 29(5): 376-97 (2010)
2008  
374
Novel nanomaterials for clinical neuroscience.
[18210200] J Neuroimmune Pharmacol 3(2): 83-94 (2008)
2010  
375
Analytical strategies for characterizing the surface chemistry of nanoparticles.
[19644676] Anal Bioanal Chem 396(3): 973-82 (2010)
2010  
376
Application of surface chemical analysis tools for characterization of nanoparticles.
[20052578] Anal Bioanal Chem 396(3): 983-1002 (2010)
2008  
377
Aptamers as molecular recognition elements for electrical nanobiosensors.
[17955221] Anal Bioanal Chem 390(4): 1023-32 (2008)
2009  
378
Designer DNA nanoarchitectures.
[19199428] Biochemistry 48(8): 1663-74 (2009)
2011  
379
Inorganic nanomaterial-based biocatalysts.
[21345305] BMB Rep 44(2): 77-86 (2011)
2005  
380
Biomedical applications of functionalised carbon nanotubes.
[15672140] Chem Commun (Camb) -(5): 571-7 (2005)
2005  
381
Surface recognition of biomacromolecules using nanoparticle receptors.
[15645020] Chem Commun (Camb) -(3): 303-12 (2005)
2007  
382
Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.
[17668088] Chem Commun (Camb) -(31): 3236-45 (2007)
2007  
383
Advances on the nanostructuration of magnetic molecules on surfaces: the case of single-molecule magnets (SMM).
[17851601] Chem Commun (Camb) -(36): 3699-707 (2007)
2007  
384
Chiral catalysis in nanopores of mesoporous materials.
[17264889] Chem Commun (Camb) -(6): 547-58 (2007)
2009  
385
Polymeric nanomedicine for cancer MR imaging and drug delivery.
[19521593] Chem Commun (Camb) -(24): 3497-510 (2009)
2008  
386
High-definition self-assemblies driven by the hydrophobic effect: synthesis and properties of a supramolecular nanocapsule.
[18685753] Chem Commun (Camb) -(32): 3709-16 (2008)
2008  
387
Biochemical applications of ultrathin films of enzymes, polyions and DNA.
[18092072] Chem Commun (Camb) -(2): 141-54 (2008)
2008  
388
Chemical sensing and imaging with metallic nanorods.
[18209787] Chem Commun (Camb) -(5): 544-57 (2008)
2010  
389
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?
[20629172] Stem Cells 28(9): 1686-702 (2010)
2006  
390
Nanotechnology for membranes, filters and sieves. A series of mini-reviews covering new trends in fundamental and applied research, and potential applications of miniaturised technologies.
[16372065] Lab Chip 6(1): 19-23 (2006)
2008  
391
Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing.
[18941687] Lab Chip 8(11): 1864-78 (2008)
2010  
392
Introduction to metallic nanoparticles.
[21180459] J Pharm Bioallied Sci 2(4): 282-9 (2010)
2010  
393
Single molecule sensing by nanopores and nanopore devices.
[20174694] Analyst 135(3): 441-51 (2010)
2010  
394
Analysis of single nucleic acid molecules with protein nanopores.
[20627172] Methods Enzymol 475(-): 591-623 (2010)
2004  
395
2006  
396
Electrophoresis in nanochannels: brief review and speculation.
[17116262] J Nanobiotechnology 4(-): 12 (2006)
2011  
397
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds.
[21812950] J Nanobiotechnology 9(-): 30 (2011)
2007  
398
Nanobiotechnology today: focus on nanoparticles.
[18163916] J Nanobiotechnology 5(-): 11 (2007)
2011  
399
Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology.
[21720680] Biol Res 44(1): 43-51 (2011)
2009  
400
Tailored carbon nanotubes for tissue engineering applications.
[19496152] Biotechnol Prog 25(3): 709-21 (2009)
2011  
401
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.
[21720501] Int J Nanomedicine 6(-): 877-95 (2011)
2011  
402
Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin.
[21753873] Int J Nanomedicine 6(-): 1217-27 (2011)
2011  
403
Reducing infections through nanotechnology and nanoparticles.
[21796248] Int J Nanomedicine 6(-): 1463-73 (2011)
2011  
404
Nanotoxicology and nanoparticle safety in biomedical designs.
[21698080] Int J Nanomedicine 6(-): 1117-27 (2011)
2007  
405
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).
[17722511] Int J Nanomedicine 2(1): 39-47 (2007)
2006  
406
Editorial: DNA-based nanoarchitectures and nanomachines.
[17036127] Org Biomol Chem 4(18): 3381-2 (2006)
2006  
407
DNA nanomachines and nanostructures involving quadruplexes.
[17036128] Org Biomol Chem 4(18): 3383-91 (2006)
2005  
408
DNA-programmed assembly of nanostructures.
[16267576] Org Biomol Chem 3(22): 4023-37 (2005)
2004  
409
Multivalency in supramolecular chemistry and nanofabrication.
[15565230] Org Biomol Chem 2(23): 3409-24 (2004)
2007  
410
Engineering proteins with tailored nanomechanical properties: a single molecule approach.
[17943196] Org Biomol Chem 5(21): 3399-406 (2007)
2010  
411
Subchronic oral toxicity of silver nanoparticles.
[20691052] Part Fibre Toxicol 7(-): 20 (2010)
2011  
412
Nanoparticle exposure at nanotechnology workplaces: a review.
[21794132] Part Fibre Toxicol 8(-): 22 (2011)
2011  
413
Reflections on the scope and the future of Particle and Fibre Toxicology.
[21457537] Part Fibre Toxicol 8(-): 13 (2011)
2010  
414
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma.
[20307263] Part Fibre Toxicol 7(-): 5 (2010)
2009  
415
Identification of the mechanisms that drive the toxicity of TiO(2 )particulates: the contribution of physicochemical characteristics.
[20017923] Part Fibre Toxicol 6(-): 33 (2009)
2010  
416
The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.
[19901017] Toxicol Sci 114(2): 162-82 (2010)
2009  
417
Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months.
[19584127] Toxicol Sci 112(2): 468-81 (2009)
2010  
418
Frontiers in cancer nanomedicine: directing mass transport through biological barriers.
[20079548] Trends Biotechnol 28(4): 181-8 (2010)
2007  
419
Ion channels and pores, made from scratch.
[17882329] Mol Biosyst 3(10): 658-66 (2007)
2007  
420
Developing synthetic conical nanopores for biosensing applications.
[17882330] Mol Biosyst 3(10): 667-85 (2007)
2009  
421
Recent progress toward the templated synthesis and directed evolution of sequence-defined synthetic polymers.
[19318208] Chem Biol 16(3): 265-76 (2009)
2009  
422
Frameworks for programming biological function through RNA parts and devices.
[19318211] Chem Biol 16(3): 298-310 (2009)
2006  
423
Writing with molecules on molecular printboards.
[16751880] Dalton Trans -(23): 2737-41 (2006)
2011  
424
Anisotropic nanomaterials: structure, growth, assembly, and functions.
[22110867] Nano Rev 2(-): - (2011)
2010  
425
Viral nanoparticles as platforms for next-generation therapeutics and imaging devices.
[20433947] Nanomedicine 6(5): 634-41 (2010)
2010  
426
Nanotopographical modification: a regulator of cellular function through focal adhesions.
[20138244] Nanomedicine 6(5): 619-33 (2010)
2008  
427
Nonviral gene transfection nanoparticles: function and applications in the brain.
[18313990] Nanomedicine 4(2): 89-97 (2008)
2010  
428
Nanodelivery in airway diseases: challenges and therapeutic applications.
[19616124] Nanomedicine 6(2): 237-44 (2010)
2011  
429
Al2O3-based nanofluids: a review.
[21762528] Nanoscale Res Lett 6(-): 456 (2011)
2011  
430
Atom devices based on single dopants in silicon nanostructures.
[21801408] Nanoscale Res Lett 6(-): 479 (2011)
2011  
431
Enhancement of critical heat flux in nucleate boiling of nanofluids: a state-of-art review.
[21711949] Nanoscale Res Lett 6(1): 415 (2011)
2011  
432
Review of thermo-physical properties, wetting and heat transfer characteristics of nanofluids and their applicability in industrial quench heat treatment.
[21711877] Nanoscale Res Lett 6(1): 334 (2011)
2011  
433
Scaling properties of ballistic nano-transistors.
[21711899] Nanoscale Res Lett 6(1): 365 (2011)
2011  
434
A review on boiling heat transfer enhancement with nanofluids.
[21711794] Nanoscale Res Lett 6(1): 280 (2011)
2011  
435
Experimental and theoretical studies of nanofluid thermal conductivity enhancement: a review.
[21711739] Nanoscale Res Lett 6(1): 229 (2011)
2011  
436
Electrorheology of nanofiber suspensions.
[21711790] Nanoscale Res Lett 6(1): 256 (2011)
2011  
437
Anomalous heat transfer modes of nanofluids: a review based on statistical analysis.
[21711932] Nanoscale Res Lett 6(1): 391 (2011)
2011  
438
A review of experimental investigations on thermal phenomena in nanofluids.
[21711918] Nanoscale Res Lett 6(1): 377 (2011)
2011  
439
The application of carbon nanotubes in target drug delivery systems for cancer therapies.
[21995320] Nanoscale Res Lett 6(-): 555 (2011)
2010  
440
2009  
441
Advances and prospect of nanotechnology in stem cells.
[20596412] Nanoscale Res Lett 4(7): 593-605 (2009)
2010  
442
High-performance nanostructured MR contrast probes.
[20694208] Nanoscale 2(10): 1884-91 (2010)
2010  
443
Nanoparticle stability from the nano to the meso interval.
[20644815] Nanoscale 2(3): 335-42 (2010)
2009  
444
Self-healing at the nanoscale.
[20644863] Nanoscale 1(1): 74-88 (2009)
2010  
445
Electrospun nanofibers for neural tissue engineering.
[20648362] Nanoscale 2(1): 35-44 (2010)
2009  
446
Multimodal drug delivery using gold nanoparticles.
[20644861] Nanoscale 1(1): 61-7 (2009)
2008  
447
The potential and challenges of nanopore sequencing.
[18846088] Nat Biotechnol 26(10): 1146-53 (2008)
2009  
448
Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots.
[19379767] Toxicol Appl Pharmacol 238(3): 280-8 (2009)
2011  
449
Nanotechnology-mediated targeting of tumor angiogenesis.
[21349160] Vasc Cell 3(1): 3 (2011)
2011  
450
Surface induced self-organization of comb-like macromolecules.
[22003463] Beilstein J Nanotechnol 2(-): 569-84 (2011)
2010  
451
Uniform excitations in magnetic nanoparticles.
[21977393] Beilstein J Nanotechnol 1(-): 48-54 (2010)
2010  
452
Review and outlook: from single nanoparticles to self-assembled monolayers and granular GMR sensors.
[21977397] Beilstein J Nanotechnol 1(-): 75-93 (2010)
2010  
453
Magnetic nanoparticles for biomedical NMR-based diagnostics.
[21977404] Beilstein J Nanotechnol 1(-): 142-54 (2010)
2010  
454
Applications of biological pores in nanomedicine, sensing, and nanoelectronics.
[20561776] Curr Opin Biotechnol 21(4): 439-76 (2010)
2011  
455
2011  
456
2010  
457
2010  
458
Axon repair: surgical application at a subcellular scale.
[20101712] Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(2): 151-61 (2010)
2010  
459
2010  
460
Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals.
[20166124] Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(3): 249-59 (2010)
2009  
461
2011  
462
Gold nanoparticle probes for the detection of mercury, lead and copper ions.
[21157604] Analyst 136(5): 863-71 (2011)
2011  
463
Luminescent lanthanide complexes as analytical tools in anion sensing, pH indication and protein recognition.
[21170445] Analyst 136(3): 431-5 (2011)
2010  
464
Magnetic nanoparticles and neurotoxins for treating atrial fibrillation: a new way to get burned?
[21135362] Circulation 122(25): 2642-4 (2010)
2010  
465
Array-based sensing with nanoparticles: 'chemical noses' for sensing biomolecules and cell surfaces.
[20801707] Curr Opin Chem Biol 14(6): 728-36 (2010)
2010  
466
A general approach to differential sensing using synthetic molecular receptors.
[20801075] Curr Opin Chem Biol 14(6): 685-92 (2010)
2010  
467
Synthetic receptors with antibody-like binding affinities.
[20674471] Curr Opin Chem Biol 14(6): 713-20 (2010)
2011  
468
Separation and/or selective enrichment of single-walled carbon nanotubes based on their electronic properties.
[21135943] Chem Soc Rev 40(3): 1324-36 (2011)
2011  
469
Phase transfer and its applications in nanotechnology.
[21120233] Chem Soc Rev 40(3): 1672-96 (2011)
2011  
470
Liquid-crystal nanoscience: an emerging avenue of soft self-assembly.
[21125105] Chem Soc Rev 40(1): 306-19 (2011)
2011  
471
Optical chemical sensors based on hybrid organic-inorganic sol-gel nanoreactors.
[21180764] Chem Soc Rev 40(2): 621-39 (2011)
2011  
472
From diatoms to silica-based biohybrids.
[21173981] Chem Soc Rev 40(2): 849-59 (2011)
2011  
473
Molecular and supramolecular dynamics of hybrid organic-inorganic interfaces for the rational construction of advanced hybrid nanomaterials.
[21170460] Chem Soc Rev 40(2): 829-48 (2011)
2010  
474
Reporters in the nanoworld: diffusion of single molecules in mesoporous materials.
[20972499] Chem Soc Rev 39(12): 4731-40 (2010)
2010  
475
Nanobiotechnology applications of reconstituted high density lipoprotein.
[21122135] J Nanobiotechnology 8(): 28 (2010)
2010  
476
Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.
[21121373] J Nanosci Nanotechnol 10(12): 8610-6 (2010)
2010  
477
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.
[20725771] Pharm Res 27(12): 2569-89 (2010)
2010  
478
2011  
479
Nanotoxicology--a pathologist's perspective.
[21422259] Toxicol Pathol 39(2): 301-24 (2011)
2011  
480
The new toxicology of sophisticated materials: nanotoxicology and beyond.
[21177774] Toxicol Sci 120 Suppl 1(): S109-29 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nanomedicine.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Nanomedicine.php on line 92